PRESENTATION Acquisition of Tahoe August 13, 2018 Tickers: CSE - - - PowerPoint PPT Presentation
PRESENTATION Acquisition of Tahoe August 13, 2018 Tickers: CSE - - - PowerPoint PPT Presentation
PRESENTATION Acquisition of Tahoe August 13, 2018 Tickers: CSE - GLH OTCQB - GLDFF Disclaimer **THIS IS NOT AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY SECURITIES OF GLH** Securities Laws This Presentation is for informational
2
Disclaimer
Securities Laws This Presentation is for informational purposes and does not constitute an offer or a solicitation of an offer to purchase the securities referred to herein. To date, the securities of GLH have not been registered under the United States Securities Act of 1933, as amended (the “Securities Act”). Prior to any future offer or sale of GLH securities other than pursuant to a registration under the Securities Act, prospective investors will be required to make representations with respect to their net worth or income and to represent, among other things, that they qualify as “Accredited Investors” (as defined under Rule 506 of Regulation D of the Securities Act) and are familiar with and understand the terms of the offering and have all requisite authority to make such
- investment. No sales shall be made until GLH and the potential investor enters into a subscription agreement for GLH securities.
No person is authorized to give any information or to make any representation not contained in this document or a subsequent offering memorandum and, if given, such other information or representation must not be relied upon. Market and Industry Data This Presentation includes market and industry data that has been obtained from third party sources, including industry publications. GLH believes that such data is accurate and that the estimates and assumptions are reasonable, but there is no assurance as to the accuracy or completeness of this data. Third party sources generally state that the information contained therein has been obtained from sources believed to be reliable, but there is no assurance as to the accuracy or completeness of included information. Although the data is believed to be reliable, Golden Leaf has not independently verified any of the data from third party sources referred to in this Presentation or ascertained the underlying economic assumptions relied upon by such sources. Additional Information Additional information pertaining to Golden Leaf has been filed electronically through SEDAR and is available at www.sedar.com or Golden Leaf’s website at www.goldenleafholdings.com. Cautionary Note on Forward Looking Information This Presentation contains “forward-looking statements” and “forward-looking information” within the meaning of applicable securities laws (collectively, “forward-looking information”) with respect to Golden Leaf Holdings Ltd (“GLH” or the “Company”) and its subsidiaries. Statements in this Presentation that are forward-looking information are subject to various risks and uncertainties concerning the specific factors disclosed herein and elsewhere in GLH’s periodic filings with Canadian securities regulators. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, will”, “projects”, or “believes” or variations (including negative variations) of such words and phrases, or statements that certain actions, events, results or conditions “may”, “could”, “would”, “might” or “will” be taken, occur or be
- achieved. Except for statements of historical fact, information contained herein constitutes forward-looking information, including, but not limited to: completion of the acquisition (the
“Acquisition”) of Tahoe (as defined herein) on the terms and timeline as set out herein, or at all, the anticipated pro forma ownership of the Company following the Acquisition, information pertaining to Tahoe’s California facility, including its development plans and production capacity, the successful integration of Tahoe’s operations into those of the Company and resulting margin expansion, and the anticipated future size of the California market for cannabis. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management at the date the statements are made including among other things assumptions about: the ability to complete the Acquisition on the terms and timeline as set out herein, or at all, there being no material changes to the anticipated pro forma
- wnership of the Company following the Acquisition, there being no issues arising with the development plan and/or anticipated production capacity of Tahoe’s California facility, the ability to
successfully integrate Tahoe’s operations into those of the Company and obtain the resulting margin expansion, there being no material issues with Tahoe’s licenses in California and Nevada or the renewal thereof, and there being no material changes (economic, regulatory, etc.) to the anticipated future size of the California market for cannabis. While the Company considers these assumptions to be reasonable, the assumptions are inherently subject to significant business, social, economic, political, regulatory, competitive and other risks and uncertainties, contingencies and other factors that could cause actual performance, achievements, actions, events, results or conditions to be materially different from those projected in the forward-looking information. Many assumptions are based on factors and events that are not within the control of the Company and there is no assurance they will prove to be correct. Although GLH has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking information, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are engaged in activities the Company believes to be compliant with applicable U.S. state and local law, but are currently considered illegal under U.S. federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use cannabis industry and; regulatory or political change, completion of the Acquisition on the terms and timeline as set out herein, changes in the anticipated pro forma capitalization of the Company prior to, or as a result of, the Acquisiton, Tahoe’s inability to complete the development of the California facility as described herein, or at all, material changes to the anticipated production capacity of the California facility, an inability to successfully integrate Tahoe’s operations with those of the Company, changes in the California market for cannabis. Forward-looking information involves known and unknown risks, uncertainties and other factors. Many of these risk factors and uncertainties are disclosed in the Company’s Annual MD&A for the year-ended December 31, 2017 in a section entitled “Risk Factors” and other documents the Company files with the Canadian securities regulators on SEDAR at www.sedar.com. There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in this forward-looking information may differ materially from actual results or events. Accordingly, readers should not place undue reliance on forward-looking information. The forward-looking Information in this Presentation is made as of the date of this Presentation. GLH disclaims any intention or obligation to update or revise such information, except as required by applicable law, and GLH does not assume any liability for disclosure relating to any other company mentioned herein.
**THIS IS NOT AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY SECURITIES OF GLH**
3
- Golden Leaf intends to acquire the
Nevada and California assets of Tahoe Hydroponics and 11T Corp. (collectively “Tahoe”)
- Provides immediate Nevada production
capacity underpinned by an extensive in- state distribution platform
- Further provides an immediate
expansion platform for California, with a ~28,800 ft2 facility under development
- Cash flow positive with material revenue
generation and strong growth1
- Expected to be immediately accretive
1. Based on unaudited financials 2. Based on 20-day VWAP of C$0.2050 as at August 10, 2018 3. USD:CAD exchange rate of 0.7682
Executive Summary
Transaction Value: C$52.4 million2 Consideration: 201.6 million in GLH shares (vests over 18 months plus earnout) C$11.1 million in cash3 Pro-Forma Ownership (Basic): Golden Leaf Shareholders: 74.2% Tahoe Shareholders: 25.8%
4
1. Nevada State Department of Taxation 2. Based on unaudited financials
- Award-winning cannabis cultivator headquartered in Carson City, Nevada
- Supplier to 34 dispensaries in Nevada (56% penetration across adult-use dispensaries state-wide1)
- Cultivates ultra-premium in-house cannabis strains (6x time Jack Herer Cup Award Winner)
- Existing ~21,600 ft2 facility in Carson City, Nevada has capacity of ~4,000 lb per annum
- Material revenue generation and cash flow positive2
- Second facility (~28,800 ft2) in Sacramento under development
Carson City Facility
Opened spring of 2016 Completed expansion in Q4 2017 Isolated grow rooms with high yields Demand far exceeding capacity
Sacramento Facility
Phase 1 anticipated to be operational Q1 2019 Integrated flower & production facility
Tahoe Overview
28,800 ft2 facility
5
Expanded portfolio of award-winning strain varieties, genetics and brands Material cultivation capacity underpinned by an extensive distribution platform generating material revenue and positive cash flow Expansion into California, the largest cannabis market in the US, materially increasing total production capacity Continued execution of “bolt-on” acquisitions of value-added operators Highly experienced management team with complementary skill sets and expertise
2 3 1
Strategic Rationale
6
Tahoe Access Total Number of Dispensaries # County Adult-Use Dispensary License3 Tahoe Access 1 Clark 47 22 2 Washoe 11 10 3 Carson City 2 2 4 Nye 1 Total 61 34 Penetration ~56%
Nye Clark Carson City Washoe
10 11 2 2 1 22 47
Las Vegas, Nevada
Completion of Seed-to-Store Value Chain Nevada Dispensary Penetration
Distribution Cultivation Products Retail
Application in progress Manufacturing
- perations in
place Current production of ~4,000 lb Existing distribution
- 1. Bolstered Production & Distribution in Nevada
Bolstered Position In A Major Market
US$200 million in state revenue generated in first
6 months post legalization1
Completion of Seed-to-Store Value Chain
Combination of Tahoe’s cultivation and distribution
with Golden Leaf’s processing facilities
Retail applications currently in-process
Material Production Capacity & Sales
Existing Nevada facility producing ~4,000 lb per
annum with demand far exceeding supply
Material revenue generation and cash flow
positive2
Expanded Distribution Platform
Supplying 34 dispensaries and growing 56% adult-use dispensary penetration across
Nevada today
Immediate Margin Expansion
GLH currently buys flower from wholesalers to
produce its Nevada extract products
1. LV Review-Journal 2. Based on unaudited financials 3. Nevada State Department of Taxation
7
~40 Million Residents
Largest US market by population
Newly Legalized
Recreational Cannabis – Jan 1, 2018
US$3.7 Billion Market Size3
Expected by end of 2018
California Cannabis Market Overview
2.8 6.5 0.0 2.0 4.0 6.0 8.0 2016 2020 US$ billion
California Sales2
California 40% Colorado 19% Washington 11% Oregon 6% Others 24%
US Cannabis Sales1
Sales: US$8 Billion in 2017
- 2. Expansion into California – The Largest US Market
- ~28,800 ft2 cultivation facility under development in Sacramento
- Anticipated to start operations in Q1 2019
- Positioned well for near-term expansion downstream to complete its seed-to-sale vision
- Provides a strong growth platform for Golden Leaf in California, the largest US cannabis market
Tahoe provides an immediate foothold in the state of California, which is projected to be the largest US cannabis market
1. Ackrell Capital – 2018 Cannabis Investment Report 2. Cogent Valuation – Expectations for Recreational Marijuana in 2018 3. BDS Analytics
8
Sundae Driver Purple Punch
Brand Portfolio Extension
- Product portfolio revolving exclusively around
ultra-premium cannabis
- Currently sells dried flower and pre-rolls
- Proven track record of internally developing
new first-class strains and genetics − 6x time Jack Herer Cup Award Winner
- Strategic combination of Tahoe’s leading
awarding-winning cannabis strains with Golden Leaf’s award winning oils and edibles
Award Winning Strains
2016 2017 Golden Leaf Tahoe
- 3. Expanded Genetics & Brand Portfolio
Hybrid Indica Sativa
Blackjack Gelato 545 Tahoe Hydro OG Blackjack
9
- 4. Continued Acquisition of Value-Add Players
Acquisition History
Neva Nevada License ses
Leading producer & retail dispensary chain in Oregon Canadian adult-use sales license applicant / Medical marijuana consultancy
Nevada California
Oregon Canada
Nevada growing, processing and distribution license
Nevada
Leading Nevada production facility and distribution network
Nevada
California indoor cultivation facility and access to California market CA
California
Tahoe provides a strong fit with GLH’s strategy of acquiring value-added cannabis players
Past Acquisitions Current Acquisitions
CA NV WA OR
- Clear strategic fit via strengthening of GLH’s upstream operations in Nevada with enhanced distribution
- Strong geographic fit providing expansion into a new market – California, the largest US cannabis market
10
- 5. Complimentary Management Team
Bolstered management team with Ray Schiavone and Mark Bruno bringing complementary industry experience and domain knowledge
Ray Schiavone Chief Executive Officer Mark Bruno Chief Operating Officer
- 20+ years experience in marketing and finance
- Co-founder of Tahoe and responsible for developing the “Tahoe Hydro” brand
- Previously founded and was the CEO of:
− Win Financial Corp., a residential lending service that operated in 20 states − World Marketing Services, a commercial marketing strategy company
- Previously co-founded ZooGrab.com, an online auction site
- Brings 10+ years in cannabis experience (retail and wholesale)
- Co-founder of Tahoe and is an award-winning hydroponic cultivation expert
- Designed THC’s highly efficient “micro climates”
- Previously the Non-Profit Director of two medical dispensaries
- Previously an owner of Imperial Home Mortgage, a US based mortgage
company
11
Transaction Value
- C$52.4 million1
Consideration
- C$11.1 million in cash2 (US$8.5 million); and
- 201.6 million in shares
Shares Earnout & Vesting
- 40.3 million shares upon closing
- 40.3 million shares upon closing or upon completion of Tahoe’s audited
financial statements, whichever is later
- 40.3 million shares 12 months from close
- 40.3 million shares 18 months from close
- 40.3 million shares upon achieving six consecutive months of production
- f at least 220 pounds of flower3
Pro Forma Ownership (Basic)
- 74.2% Golden Leaf Shareholders
- 25.8% Tahoe Shareholders
Timing
- Closing expected in October 2018
1. Based on 20-day VWAP of C$0.2050 as at August 10, 2018 2. USD:CAD exchange rate of 0.7682 3. Subject to adjustment based on percentage of 220-pound monthly yield that is achieved
Deal Terms
12
Certain Key Business & Industry Risk Factors
An investment in the securities of the Company is risky and involves a material risk of complete loss. The following is not intended to be an exhaustive list of the risks associated with the business of the Company. Rather, the key risks set out below relate solely to the regulation of the marijuana industry in the United States. Nothing contained in this Presentation is or may be relied on as a promise or representation as to any future performance or event. The information set out in this Presentation speaks only as of August 10, 2018 and the Company assumes no obligation to update such information. The information set out in this Presentation does not purport to contain all information that might be required to evaluate an investment in the Company, and the subscriber must conduct its own independent analysis. References to the Company herein include subsidiaries of the Company and Tahoe, as applicable. Marijuana remains illegal under U.S. federal law. Under the Federal Controlled Substances Act of 1970 (the “Federal CSA”), marijuana is classified as a Schedule I drug. Even in those states in which the use of marijuana has been legalized, its production, manufacture, processing, possession, distribution, sale and use remains a federal crime. Since U.S. federal law criminalizing marijuana pre-empts state laws that legalize it, strict enforcement of federal law regarding marijuana would result in the Company’s inability to proceed with its business plan. Currently, there are 30 states in the United States plus the District of Columbia that have laws and/or regulations that recognize, in one form or another, legitimate medical uses for marijuana and consumer use of marijuana. Although the Company believes its business activities are compliant with applicable state and local law, strict compliance with state and local laws with respect to marijuana may neither absolve the Company of liability under United States federal law, nor may it provide a defense to any federal proceeding which may be brought against the Company. Any such proceedings brought against the Company may adversely affect the Company’s operations and financial performance. Although federally illegal, the U.S. federal government’s approach to enforcement of such laws has at least until recently trended toward non-enforcement. On August 29, 2013, the U.S. Department of Justice (“DOJ”), issued a memorandum known as the “Cole Memorandum” to all U.S. Attorneys’ offices (federal prosecutors). The Cole Memorandum generally directed U.S. Attorneys not to prioritize the enforcement of federal marijuana laws against individuals and businesses that rigorously comply with state regulatory provisions in states with strictly regulated medical or recreational cannabis programs. While not legally binding, and merely prosecutorial guidance, the Cole Memorandum laid a framework for managing the tension between state and federal laws concerning state regulated marijuana businesses. However, on January 4, 2018 the Cole Memorandum was revoked by Attorney General Jeff Sessions. While this did not create a change in federal law, as the Cole Memorandum was not itself law, the revocation removed the DOJ’s guidance to U.S. Attorneys that state-regulated cannabis industries substantively in compliance with the Cole Memorandum’s guidelines should not be a prosecutorial priority. In addition to his revocation of the Cole Memorandum, A.G. Sessions also issued a one-page memorandum known as the “Sessions Memorandum”. The Sessions Memorandum confirmed the rescission of the Cole Memorandum and explained the rationale of the DOJ in doing so: the Cole Memorandum, according to the Sessions Memorandum, was “unnecessary” due to existing general enforcement guidance adopted in the 1980s, as set forth in the U.S. Attorney’s Manual (the “USAM”). The USAM enforcement priorities, like those of the Cole Memorandum, are also based on the federal government’s limited resources, and include “law enforcement priorities set by the Attorney General,” the “seriousness” of the alleged crimes, the deterrent effect of criminal prosecution” and “the cumulative impact of particular crimes on the community.” While the Sessions Memorandum emphasizes that marijuana is a Schedule I controlled substance, and reiterates the statutory view that cannabis is a “dangerous drug and that marijuana activity is a serious crime”, it is unclear what prosecutorial effects will be created by the rescission of the Cole Memorandum. Accordingly, the Company cannot provide any assurance that the DOJ will not initiate the enforcement of federal law regarding the production, manufacture, processing, possession, distribution, sale and use of marijuana. Regardless, marijuana remains a Schedule I controlled substance at the federal level, and neither the Cole Memorandum nor its rescission has altered that fact. The federal government of the United States has always reserved the right to enforce federal law in regard to the sale and disbursement of medical or recreational marijuana, even if state law sanctioned such sale and disbursement. The Company’s business is highly regulated and it may not be issued necessary licenses, permits and cards. The Company’s business and products are and will continue to be regulated as applicable laws continue to change and develop. Regulatory compliance and the process of obtaining regulatory approvals can be costly and time-consuming. No assurance can be given that the Company will be able to maintain the requisite licenses, permits or authorizations to operate its business in
- California. Further, the Company plans to continue expanding its operations in other States and in other jurisdictions. No assurance can be given that the Company will be able to obtain the
requisite licenses, permits or authorizations to operate its business in these jurisdictions. Further the Company cannot predict what kind of regulatory requirements its business will be subject to in the future. Laws will continue to change rapidly for the foreseeable future. Local, state and federal laws and enforcement policies concerning marijuana-related conduct are changing rapidly and will continue to do so for the foreseeable future. Changes in applicable law are unpredictable and could have a material adverse effect on the Company’s business.